Get the Stockscreener App
27.57
4.77%
-1.38
After Hours:
27.57
Harrow Inc stock is traded at $27.57, with a volume of 444.00K.
It is down -4.77% in the last 24 hours and down -17.38% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
See More
Previous Close:
$28.95
Open:
$29.06
24h Volume:
444.00K
Relative Volume:
1.19
Market Cap:
$981.90M
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-28.72
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
-9.37%
1M Performance:
-17.38%
6M Performance:
-35.43%
1Y Performance:
+152.01%
1-Day Range:
$26.79
$29.08
1-Week Range:
$26.79
$31.54
52-Week Range:
$9.30
$59.23
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
102 WOODMONT BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
27.57 | 981.90M | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-25 | Initiated | H.C. Wainwright | Buy |
| Dec-04-24 | Reiterated | B. Riley Securities | Buy |
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
View All
Harrow Inc Stock (HROW) Latest News
Implied Volatility Surging for Harrow (HROW) Stock Options - Nasdaq
Harrow (NASDAQ:HROW) shareholders have earned a 40% CAGR over the last five years - Yahoo Finance
Shareholders Should Be Pleased With Harrow, Inc.'s (NASDAQ:HROW) Price - Simply Wall St
Equitable Trust Co. Sells 14,670 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 5.1%Here's What Happened - MarketBeat
Bleakley Financial Group LLC Buys 3,394 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
What is HC Wainwright's Forecast for Harrow Q4 Earnings? - MarketBeat
HC Wainwright Comments on Harrow’s Q4 Earnings (NASDAQ:HROW) - Defense World
Harrow (NASDAQ:HROW) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
H.C. Wainwright sets $57 target on Harrow Health stock - MSN
HC Wainwright & Co. Initiates Coverage of Harrow (HROW) with Buy Recommendation - MSN
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
15,448 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Sonora Investment Management Group LLC - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.6%Here's What Happened - MarketBeat
Fungal Keratitis Treatment Market Growth By 2031 | Harrow Inc., - openPR
SG Americas Securities LLC Acquires 18,815 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
SG Americas Securities LLC Boosts Stake in Harrow, Inc. (NASDAQ:HROW) - Defense World
Commit To Buy Harrow At $23, Earn 18% Annualized Using Options - Nasdaq
Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 - GlobeNewswire Inc.
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients - Business Wire
Harrow Launches 'Harrow Cares' Patient Support Program with Cencora Partnership - StockTitan
Harrow, Inc. (NASDAQ:HROW) Sees Board Member Resignation - Defense World
Opaleye Management Inc. Significantly Reduces Stake in Harrow Inc. - GuruFocus.com
Opaleye management sells $711,814 worth of Harrow shares By Investing.com - Investing.com South Africa
Harrow (NASDAQ:HROW) Trading Down 4.9%Time to Sell? - MarketBeat
Assenagon Asset Management S.A. Sells 79,071 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Brookstone Capital Management Invests $275,000 in Harrow, Inc. (NASDAQ:HROW) - Defense World
Brookstone Capital Management Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.1%Should You Sell? - MarketBeat
JPMorgan Chase & Co. Purchases 194,480 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Harrow appoints new Chief Scientific Officer - Investing.com
Harrow announces Amir Shojaei, PharmD, PhD joins as CSO - TipRanks
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer - Business Wire
Principal Financial Group Inc. Takes Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Inc (NASDAQ: HROW): On Track To A Higher Share Price - Stocks Register
Those Derisked Baby Bonds Of Harrow, Inc (NASDAQ:HROWM) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Up 7.7%Should You Buy? - MarketBeat
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):